Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure

Febrile neutropenia (FN) is a serious complication of chemotherapy, which can cause significant morbidity and mortality, result in dose delays and reductions and, ultimately, reduce cancer survival. Over the past decade, the availability of biosimilar filgrastim (short-acting granulocyte colony-stim...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornes, Paul, Gascon, Pere, Vulto, Arnold G., Aapro, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211191/
https://www.ncbi.nlm.nih.gov/pubmed/32232676
http://dx.doi.org/10.1007/s40259-020-00411-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211191/
https://www.ncbi.nlm.nih.gov/pubmed/32232676
http://dx.doi.org/10.1007/s40259-020-00411-4

Ejemplares similares